Featuring David Boaz, Executive Vice President, Cato Institute; and Matt Welch, Editor in Chief, Reason; vs. Ramesh Ponnuru, Columnist and Senior Editor, National Review; and Conor Friedersdorf, Staff Writer, The Atlantic; moderated by David Kirby, Vice President and Senior Fellow, Cato Institute.
Every imaginable product and service has a price, and yet there is something different about pricing prescription medicines. In the new issue of Regulation, Charles L. Hooper and David R. Henderson say that to “fix” drug pricing, we need more competition, more cost sharing, and the liberalization of some regulations. Also in this issue, Larry Downes describes how rent-seeking and public choice have put a telecom deregulation success story at risk, and Jason Scott Johnston looks at the social cost of carbon – how is it derived and how is it used to justify America’s climate policy?
Published in the wake of the Supreme Court’s landmark decision in Kelo v. New London, Cornerstone of Liberty: Property Rights in 21st Century America made a powerful contribution to the firestorm of interest in protecting property rights. Now in its second edition, Cornerstone of Liberty has been fully updated by authors Timothy and Christina Sandefur, and examines how dozens of new developments in courtrooms and legislatures across the country have shifted the landscape of private property rights since 2005.
The Cato Institute has released its 2014 Annual Report, which documents a dynamic year of growth and productivity. “Libertarianism is the philosophy of freedom,” Cato’s David Boaz writes in his book, The Libertarian Mind. “It is the indispensable framework for the future.” And as the new report demonstrates, the Cato Institute, thanks largely to the generosity of our Sponsors, is leading the charge to apply this framework across the policy spectrum.
Featuring Ted Galen Carpenter, Vice President for Defense and Foreign Policy Studies, Cato Institute; and Ian Vásquez, Director of the Center for Global Liberty and Prosperity, Cato Institute.
Since President Nixon launched the War on Drugs in 1971, its escalating direct and indirect costs have become increasingly apparent. As we have seen over the decades in Colombia, Mexico, Afghanistan, and other drug-source countries, banning the drug trade creates economic distortions and an opportunity for some of the most unsavory elements to gain tenacious footholds. Drug prohibition inevitably leads to an orgy of corruption and violence. Do any perceived benefits of the current prohibitionist policies outweigh the growing costs to the United States and other countries? Please join Cato scholars Ted Carpenter and Ian Vásquez for a discussion of the international consequences of America’s war on drugs and whether alternative approaches would lead to better outcomes.